康基醫療獲由董事長鐘鳴牽頭財團溢價提私有化,今日復牌
康基醫療(9997.HK)與要約人(Knight Bidco Limited)今日聯合宣佈,雙方擬以協議安排的方式對公司進行私有化,以期公司能夠專注於長期戰略決策,包括研發長期投入及運營升級。待該方案完成後,公司將成為要約人的全資附屬公司,而公司股份於聯交所的上市地位將被撤銷。本次私有化方案設定的股票註銷價格為9.25港元/股,較股份於截至未受干擾日期(即2025年6月30日)的收盤價7.6港元溢價約21.7%;較股份於截至未受干擾日期(包括該日)止120個交易日的平均收盤價每股約7.13港元溢價約29.7%;較截至未受干擾日期(包括該日)止360個交易日平均收盤價每股約6.28港元溢價約47.3%;較去年底每股資產淨值2.39港元溢價2.9倍。該方案為少數股東提供具吸引力的退出機會,使其能在市場波動、行業及宏觀不確定性,以及於康基醫療的股份持續面臨交易價格壓力及流動性受限之際,以顯著高於未受干擾股價的溢價變現其於公司的權益。同時也為康基醫療及其股東提供有效的解決方案,緩解康基醫療面臨的短期業績指標壓力,使其能夠專注於長遠戰略決策。集團指,註銷價格不會予以增加,要約人不保留增加註銷價格的權利。私有化現金代價約58.2億港元。要約人由一個財團持有,包括另類資產管理公司TPG等。自7月18日起停牌的康基醫療今日復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.